Restoration of miR-124 serves as a promising therapeutic approach in CRC by affecting CDK6 which is itself a prognostic and diagnostic factor-Reference-Cited by-同舟云学术

Restoration of miR-124 serves as a promising therapeutic approach in CRC by affecting CDK6 which is itself a prognostic and diagnostic factor

Published:2021-09 Issue: Volume:24 Page:101274
ISSN:2452-0144
Container-title:Gene Reports
language:en
Short-container-title:Gene Reports

Author:

Akbari Morteza,Adili Ali,Faraji Afsaneh,Pakdel Abbas,Aslaminabad Ramin,Nasrabadi Davoud,Sadeghvand Shahram,Saeedi Hossein,Tahavori Mina,Shabani Aliakbar,Baradaran Behzad

Publisher

Elsevier BV

Subject

Genetics

Reference52 articles.

1. Predicting effective microRNA target sites in mammalian mRNAs;Agarwal;Elife,2015

2. Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia;Agirre;Cancer Res.,2009

3. CD133: an emerging prognostic factor and therapeutic target in colorectal cancer;Akbari;Cell Biol. Int.,2019

4. Effects of CD133 silencing on survival and migration of HT-29 colorectal cancer cells;Akbari;Iran. J. Immunol.,2019

5. Evaluation of the methylation of MIR129-2 gene in gastric cancer;Alizadeh;J. Gastrointest. Cancer,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A potential function for MicroRNA-124 in normal and pathological bone conditions;Non-coding RNA Research;2024-09

2. Double-edged sword role of miRNA-633 and miRNA-181 in human cancers;Pathology - Research and Practice;2023-08

3. SARS-CoV-2-associated gut microbiome alteration; A new contributor to colorectal cancer pathogenesis;Pathology - Research and Practice;2022-11

4. Association between microRNAs and chemoresistance in pancreatic cancer: Current knowledge, new insights, and forthcoming perspectives;Pathology - Research and Practice;2022-08